Kezia Gaitskell
BM BCh MA (Oxon) MSc DPhil FRCPath
Consultant Pathologist and Honorary Visiting Research Fellow
Dr Kezia Gaitskell joined the Cancer Epidemiology Unit (CEU) in 2013, and studied for a DPhil as part of the Cancer Research UK Oxford Centre’s Clinical Research Training Fellowship programme.
Her main research interest is in the interface between histopathology and epidemiology. For her DPhil, she explored epidemiological risk factors for ovarian cancer in the Million Women Study cohort, and how this varies by histological subtype. For her postdoctoral research, she continues to investigate variation in risk factors for different histological types of cancer.
Since completing her clinical training in 2022, she has continued with research and teaching alongside working as a Locum Consultant in Histopathology at Oxford University Hospitals.
Prior to coming to the Unit, she studied medicine at Oxford, trained as a histopathology registrar in London, and completed an MSc in Epidemiology at the London School of Hygiene & Tropical Medicine. In 2018 she took up a post as an NIHR-funded Academic Clinical Lecturer in Histopathology in the Nuffield Division of Clinical Laboratory Sciences.
Recent publications
-
Integrating histopathology and epidemiology to explore cancer aetiology and survival
Journal article
GAITSKELL K., (2025), Diagnostic Histopathology
-
Self-interactive learning: Fusion and evolution of multi-scale histomorphology features for molecular traits prediction in computational pathology.
Journal article
Hu Y. et al, (2025), Med Image Anal, 101
-
Amount and intensity of daily total physical activity, step count and risk of incident cancer in the UK Biobank.
Journal article
Shreves AH. et al, (2025), Br J Sports Med
-
Cervicitis decidualis mimicking cervical cancer in pregnancy.
Journal article
Soleymani Majd H. et al, (2025), Gynecol Oncol Rep, 57
-
The surgical, histopathological characteristics, and survival outcome of ovarian clear cell carcinoma: a retrospective case series sharing the experience of a tertiary cancer centre.
Journal article
El Tawab S. et al, (2024), Transl Cancer Res, 13, 5037 - 5049